Cannabis
U.S. Republicans move to decriminalize marijuana at federal level (Reuters)
Germany Set To Legalize Marijuana Nationwide After Major Parties Reach Agreement (Marijuana Moment)
Brazil is on The Brink of Medical Cannabis Change (High Times)
Is This The First Real Case Of Fentanyl-Tainted Marijuana In The U.S.? (Forbes)
Indiana Democratic Party Backs Marijuana Legalization And Pledges 2022 Reform Push (Marijuana Moment)
New York Senator Files Bill To Extend Marijuana Equity Benefits To Transgender And Non-Binary People (Marijuana Moment)
Straws Lined with THC Could Transform Edibles Industry (High Times)
Bipartisan Wisconsin Lawmakers Unveil Marijuana Decriminalization Bill (Marijuana Moment)
New study shows no increase in car crash injuries after marijuana legalized (Vancouver Sun)
Canadian Groups Gives Free Weed And Edibles To Fight Opioid Abuse (High Times)
Marijuana Legalization Attitudes Vary Significantly Within Partisan Coalitions, Pew Survey Shows (Marijuana Moment)
Creating a better cannabis cultivation facility while strengthening relationships with third-party testing labs (Marijuana Business Daily)
Sturdy Hemp Structures Could be the Future Eco-Building (High Times)
Using cannabis in pregnancy linked to aggression and anxiety in children, a study suggests (CNN)
Study: Scarification of cannabis seeds, certain disinfectants boost germination rates (Marijuana Business Daily)
LSD
MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures (Psilocybin Alpha)
Up, Up and Away: The Trippy Tales Behind ‘Flying Over Sunset’ (The New York Times)
Is LSD Safe - Latest Research Findings (Drug Science)
The LSD Comedown: Navigating the After Effects of Acid (DoubleBlind)
Magic Mushrooms
Bill on magic mushrooms aims to make Pa. a national leader in psychedelic research (The Philadelphia Inquirer)
NYC Subways Ban Marijuana And Psychedelic Mushroom Ads (Marijuana Moment)
Magic Mushrooms, A Love Story (The New Yorker)
PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch (Psilocybin Alpha)
Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders (Yahoo!)
TheraPsil and Imperial College London, McGill University Partner on Psilocybin Study (Truffle Report)
Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)
Another Life: Foraging for mushrooms and natural psychedelics (The Irish Times)
MDMA
World's 'Strongest-Ever' Ecstasy Pill Found in English Nightclub (VICE)
DMT
Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study (Yahoo!)
Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder (Psilocybin Alpha)
Ayahuasca
Is This Phoenix Pastor a Spiritual Shaman or an Ayahuasca Kingpin — or Both? (Phoenix New Times)
Ron White’s strange ayahuasca experience, as described on JRE. (Ceng News)
5-MeO-DMT
Mike Tyson ‘died’ while tripping on psychedelic toad venom (New York Post)
Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form (Business Wire)
Novel Psychoactive Substances
New Psychedelic Molecules: What’s in Development? (Truffle Report)
New Psychedelic Molecules Part II: Key Industry Players (Truffle Report)
Researchers train computers to predict the next designer drugs (ScienceDaily)
BetterLife Pharma says pharmacology data on second-generation LSD derivative confirms its projected non-hallucinogenic property (Proactive Investors)
Ketamine
Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People with Parkinson’s Disease (Yale School of Medicine)
Warning of ‘wild west’ in depression treatment as UK clinics offer ketamine (The Guardian)
Bexson Biomedical Announces Expansion to Treat Major Depression with Wearable Ketamine Formulation (PR Newswire)
Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods (Psilocybin Alpha)
DXM
Teenagers are ‘robotripping’ in the pursuit of cheap highs, again (Screenshot Media!)
Miscellaneous
Jon Hopkins’s Psychedelic Journey to a New Way of Creating Music (The New York Times)
"Aharon said it was healing:" How psychedelic therapy was undermined by abuse (Inverse)
Psychedelics Use Associated With 55 Percent Decrease In Daily Opioid Consumption, Study Finds (Marijuana Moment)
Horizons Conference Reconvenes in NYC to Connect Psychedelic Communities (Lucid News)
New Non-Profit Supports Groundbreaking HPPD or ‘Acid Flashback’ Research (Truffle Report)
Inside The Race To Create A Two-Hour Psychedelic Therapy Experience (Forbes)
Psychedelics Help Heal Childhood Trauma, Study Finds (Benzinga)
Psychedelic Bypassing: When Avoidance is Mistaken for Healing (Psychedelics Today)
Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment (Forbes)
Three Decades of Drug Policy Reform Work (Open Society Foundations)
A Close Reading of the QAnon Shaman’s Conspiracy Manifesto (Lit Hub)
Naropa University Announces Psychedelic-Assisted Therapies Certificate (Tricycle)
A New Psychedelic Organization is Merging Shamanism and Science (Lucid News)
The Serotonin 5-HT2A Receptor: From Mice to Humans (Psychedelic Science Review)
Animals That Eat Psychedelics and Enjoy the Trip (Psychedelic Spotlight)
CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction (Psilocybin Alpha)
MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease (Psilocybin Alpha)
Letting people test their drugs will reduce the number of needless deaths (The Independent)
The History of Psychedelics: An ancient tradition (Canex)
MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test (Psilocybin Alpha)
Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.
Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.